abiraterone
CHEBI:CHEBI_68642
Definition
A 3beta-sterol that is androsta-5,16-dien-3beta-ol substituted at position 17 by a 3-pyridyl group. Administered as the O-acetate, it is used for treatment of metastatic castrate-resistant prostate cancer.
Chemical Information
- Molecular Formula
- C24H31NO
- Molecular Mass
- 349.50900
- Charge
- 0
- SMILES
- [H][C@@]12CC=C3C[C@@H](O)CC[C@]3(C)[C@@]1([H])CC[C@]1(C)C(=CC[C@@]21[H])c1cccnc1
- InChI
- InChI=1S/C24H31NO/c1-23-11-9-18(26)14-17(23)5-6-19-21-8-7-20(16-4-3-13-25-15-16)24(21,2)12-10-22(19)23/h3-5,7,13,15,18-19,21-22,26H,6,8-12,14H2,1-2H3/t18-,19-,21-,22-,23-,24+/m0/s1
- InChIKey
- GZOSMCIZMLWJML-VJLLXTKPSA-N
Alternative Names
- (3beta)-17-(pyridin-3-yl)androsta-5,16-dien-3-ol
- 17-(3-Pyridyl)androsta-5,16-dien-3beta-ol
- 17-(pyridin-3-yl)androsta-5,16-dien-3beta-ol
- abiraterone
Treatment Applications
-
castration-resistant prostate carcinomaView Disease →
DOID:0080909
-
prostate small cell carcinomaView Disease →
DOID:7141
-
Barrett's adenocarcinomaView Disease →
DOID:7941
Drug Classification
-
pyridinesView Class →
CHEBI:26421
-
3beta-hydroxy-Delta(5)-steroidView Class →
CHEBI:1722
-
3beta-sterolView Class →
CHEBI:35348
-
t276340
-
t276693
-
t276726
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- oboInOwl#hasDbXref
- Wikipedia:Abiraterone
- DRON_00010000
- 1100072
- core#notation
- CHEBI:68642
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- oboInOwl#hasOBONamespace
- chebi_ontology
- oboInOwl#hasDbXref
- Wikipedia:Abiraterone
- DRON_00010000
- 1100072
- generic_name
- ABIRATERONE
- oboInOwl#id
- CHEBI:68642
- brand_name
- YONSA
- brand_name_base
- YONSA
- product_ndc
- 54893-0070
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_68640
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- chebi#has_parent_hydride
- http://purl.obolibrary.org/obo/CHEBI_35509
- rxcui
- 2046585
- active_ingredient_strength
- 1000 g/1000g
- pharm_class
- Cytochrome P450 2C8 Inhibitors [MoA]
- manufacturer_name
- Novugen Pharma (USA) LLC
- active_ingredient_name
- ABIRATERONE
- unii
- EM5OCB9YJ6
- spl_set_id
- f308b463-27e4-422a-95a2-ecbbf95eee20
- upc
- 0382293001101
- package_marketing_start_date
- 18-OCT-19
- listing_expiration_date
- 20241231
- marketing_start_date
- 20130731
- spl_id
- 0cdca9ae-195e-0bd9-e063-6394a90a2765
- labeler_name
- CivicaScript, LLC
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
- dosage_form
- POWDER
- application_number
- ANDA215947
- core#notation
- CHEBI:68642
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- route
- ORAL
- package_ndc
- 54893-0070-1
- package_description
- 50 kg in 1 DRUM (54893-0070-1)
- rdf-schema#range
- https://w3id.org/def/predibionto#has_drug_112952
- has_treatment
- http://purl.obolibrary.org/obo/DOID_3026
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect32657
- owl#annotatedSource
- t276822
- owl#someValuesFrom
- t3992115